The ingestible sensors market is expected to grow at a CAGR of 9.10%, reaching a market size of US$1.09 billion in 2029 from US$706.603 million in 2024.
Ingestible electronic systems comprise a biocompatible microprocessor, power supply, sensors, and other components, enabling the device to communicate with a mobile application for diagnosis and monitoring. These capsule-sized devices possess the potential to screen for diseases that are difficult, if not impossible, to detect at an early stage using other methods.
Furthermore, they can also reduce the facility and labour expenses typically associated with multiple procedures and offer a foundation for epithelial-targeted therapeutic interferences. These technological advancements can make disease monitoring and treatment for various conditions far more effective, enabling patients to live longer and healthier. Increased chronic diseases and advancing technologies will promote market growth in the forecasted period.
Furthermore, ongoing scientific and technological advancements that have resulted in the creation and development of tiny camera pills that are widely used in ingestible sensors as well as the introduction of cutting-edge sensor technologies by major players are significantly expanding the market's growth prospects. For example, in December 2022, engineers announced that they had created an ingestible biosensing system that is pill-shaped, battery-free, and provides real-time, continuous monitoring of the intestinal environment.
Ingestible electronic systems comprise a biocompatible microprocessor, power supply, sensors, and other components, enabling the device to communicate with a mobile application for diagnosis and monitoring. These capsule-sized devices possess the potential to screen for diseases that are difficult, if not impossible, to detect at an early stage using other methods.
Furthermore, they can also reduce the facility and labour expenses typically associated with multiple procedures and offer a foundation for epithelial-targeted therapeutic interferences. These technological advancements can make disease monitoring and treatment for various conditions far more effective, enabling patients to live longer and healthier. Increased chronic diseases and advancing technologies will promote market growth in the forecasted period.
Furthermore, ongoing scientific and technological advancements that have resulted in the creation and development of tiny camera pills that are widely used in ingestible sensors as well as the introduction of cutting-edge sensor technologies by major players are significantly expanding the market's growth prospects. For example, in December 2022, engineers announced that they had created an ingestible biosensing system that is pill-shaped, battery-free, and provides real-time, continuous monitoring of the intestinal environment.
Ingestible Sensors Market Drivers:
- The increasing prevalence of chronic health conditions due to growing sedentary lifestyles
Ingestible Sensors Market Geographical Outlook
- North America is expected to hold a significant market share in the forecast period.
Reasons for buying this report::
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive IntelligenceReport Coverage:
- Historical data & forecasts from 2022 to 2029
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Key Market Segmentation:
The ingestible sensors market is segmented and analyzed as below:- By Sensor Type
- Temperature
- Image
- pH
- Pressure
- By End-User Industry
- Healthcare
- Sports & Fitness
- By Geography
- North America
- United States
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- UK
- France
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- Israel
- Others
- Asia Pacific
- China
- Japan
- India
- Indonesia
- South Korea
- Others
- North America
Table of Contents
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
5. INGESTIBLE SENSORS MARKET BY SENSOR TYPE
6. INGESTIBLE SENSORS MARKET BY END-USER INDUSTRY
7. INGESTIBLE SENSORS MARKET BY GEOGRAPHY
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
9. COMPANY PROFILES
Companies Mentioned
Some of the key companies profiled in this Ingestible Sensors Market report include:- Otsuka Pharmaceuticals
- HQ, Inc.
- CapsoVison
- Olympus Corporation
- Atmo Biosciences
- EtectRx
- Medtronic
- Intro Medic
- Progenity (Medimetrics)
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 124 |
Published | September 2024 |
Forecast Period | 2024 - 2029 |
Estimated Market Value ( USD | $ 706.6 million |
Forecasted Market Value ( USD | $ 1090 million |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |